JSE · Healthcare

Labat Africa Ltd (LAB)

Drug Manufacturers - Specialty & Generic

Labat Africa Ltd (LAB) is listed on JSE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LAB

P/E ratio

18.00

Labat Africa Ltd (LAB) — FAQ

What is LAB's P/E ratio?

The price-to-earnings (P/E) ratio for Labat Africa Ltd (LAB) is 18.00 (data as of 2026-03-22).

Does Labat Africa Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Labat Africa Ltd (LAB). Check the MyAverix Finance app for the latest dividend data.

What sector is Labat Africa Ltd in?

Labat Africa Ltd (LAB) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is LAB listed on?

LAB is listed on JSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)